Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force

European Urology

Volumn 71, Issue 4, 2017, Pages 648-655

  Moore, Caroline M ^a,b   Giganti, Francesco ^b,c   Albertsen, Peter ^d   Allen, Clare ^b   Bangma, Chris ^e   Briganti, Alberto ^c   Carroll, Peter ^f   Haider, Masoom ^g   Kasivisvanathan, Veeru ^a,b   Kirkham, Alex ^b   Klotz, Laurence ^h   Ouzzane, Adil ⁱ   Padhani, Anwar R ^j   Panebianco, Valeria ^k   Pinto, Peter ^l   Puech, Philippe ⁱ   Rannikko, Antti ^m   Renard Penna, Raphaele ⁿ   Touijer, Karim ^o   Turkbey, Baris ^l   van Poppel, Heinrik ^p   Valdagni, Riccardo ^q,r   Walz, Jochen ^s   Schoots, Ivo ^e   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Canada   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIV LILLE   (France)

^j MOUNT VERNON HOSPITAL   (United Kingdom)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l NATIONAL CANCER INSTITUTE   (United States)

^m HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^o MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^p UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^q NATIONAL CANCER INSTITUTE   (Italy)

^r UNIVERSITY OF MILAN   (Italy)

^s INSTITUT PAOLI CALMETTES   (France)

more..

Author keywords

Active surveillance; Prostate cancer; Prostate MRI

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CLINICAL OUTCOME; COHORT ANALYSIS; CONSENSUS; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VOLUME; ADVISORY COMMITTEE; DIAGNOSTIC IMAGING; DOCUMENTATION; EUROPE; ONCOLOGY NURSING; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; PROSTATE TUMOR; RADIOLOGY; STANDARDS; TUMOR VOLUME; WATCHFUL WAITING;

ADVISORY COMMITTEES; CONSENSUS; DOCUMENTATION; EUROPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ONCOLOGY NURSING; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS; RADIOLOGY; TUMOR BURDEN; WATCHFUL WAITING;

EID: 84977517393     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2016.06.011     Document Type: Article

References (14)

1. [1] Dickinson, L., Ahmed, H.U., Allen, C., et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59 (2011), 477–494.
2. [2] Barentsz, J.O., Richenberg, J., Clements, R., et al. ESUR prostate MR guidelines 2012. Eur Radiol 22 (2012), 746–757.
3. [3] Kirkham, A.P., Haslam, P., Keanie, J.Y., et al. Prostate MRI: Who, when, and how? Report from a UK consensus meeting. Clin Radiol 68 (2013), 1016–1023.
4. [4] Weinreb, J.C., Barentsz, J.O., Choyke, P.L., et al. PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol 69 (2016), 16–40.
5. [5] Prostate cancer: diagnosis and management. National Institute for Health and Care Excellence Web site. https://www.nice.org.uk/guidance/cg175. Updated January 2014.
6. [6] Schoots, I.G., Petrides, N., Giganti, F., et al. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol 67 (2014), 627–636.
7. [7] Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method user's manual 2001. RAND Web site. http://www.rand.org/pubs/monograph_reports/MR1269.html.
8. [8] Siddiqui, M.M., Rais-Bahrami, S., Turkbey, B., et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313 (2015), 390–397.
9. [9] Walton Diaz, A., Shakir, N.A., George, A.K., et al. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. Urol Oncol 33 (2015), 202.e1–202.e7.
10. [10] Loeb, S., Walter, D., Curnyn, C., Gold, H.T., Lepor, H., Makarov, D.V., How active is active surveillance? Intensity of follow-up during active surveillance for prostate cancer in the United States. J Urol 196 (2016), 721–726.
11. [11] Mullins, J.K., Bonekamp, D., Landis, P., et al. Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int 111 (2013), 1037–1045.
12. [12] Lee, D.H., Koo, K.C., Lee, S.H., et al. Low-risk prostate cancer patients without visible tumor (t1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol. Jpn J Clin Oncol 43 (2013), 553–558.
13. [13] Rais-Bahrami, S., Türkbey, B., Rastinehad, A.R., et al. Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol 20 (2014), 293–298.
14. [14] Bruinsma, S.M., Global Action Plan on Active Surveillance for low risk PCa: Movember Foundation launches integrated project on active surveillance. Eur Urol Today, 26, 2014, 26.